BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 767388)

  • 21. [On selection of antineoplastic agents for local use].
    Pol'kina RI
    Vopr Onkol; 1969; 15(7):72-4. PubMed ID: 4980426
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
    Wagner K; Haas H; Meyerhold A
    Wien Klin Wochenschr; 1965 Sep; 77(36):589-602. PubMed ID: 5323247
    [No Abstract]   [Full Text] [Related]  

  • 23. Depot cancer chemotherapy through polymer membranes.
    Long DM; Sehgal LR; DeRios ME; Rios MV; Szanto PB; Forrest R
    Rev Surg; 1973; 30(4):229-40. PubMed ID: 4578258
    [No Abstract]   [Full Text] [Related]  

  • 24. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
    Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biological parameters of a standardized tumor model for chemotherapeutical and toxicological testing (author's transl)].
    Fichtner I; Arnold W; Pehl E
    Arch Geschwulstforsch; 1979; 49(5):391-407. PubMed ID: 518249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of transplantability indices of tumor cells for evaluation of the cytotoxic effect of antineoplastic agents in vitro].
    Merkulov MF; Leskova SG
    Farmakol Toksikol; 1972; 35(1):84-90. PubMed ID: 4622159
    [No Abstract]   [Full Text] [Related]  

  • 28. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
    Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
    Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acceleration of growth of transplantable tumors and change in the sensitivity to chemotherapy on administration of creatinine].
    Pukhal'skaia ECh; Platonova GN
    Biull Eksp Biol Med; 1971 Oct; 72(10):82-5. PubMed ID: 5126158
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental principles of immunotherapy using microbial substances in malignant tumors. 1. Effect of streptococci on ascite retothelsarcoma in the mouse in vitro].
    Huth E
    Fortschr Med; 1977 May; 95(20):1359-64. PubMed ID: 326651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of additional chemotherapeutic agents employing Sarcoma 180 in mice.
    Field JB; Kloetzel MC; Thienes CH; Mireles A; Dolendo EC
    Cancer Res; 1964 Jan; 24(1 Pt 1):40-144. PubMed ID: 5878217
    [No Abstract]   [Full Text] [Related]  

  • 32. Regression of transplantable immunoglobulin-secreting rat tumors by irradiation and chemotherapy and induction of transplantation resistance.
    Deckers C; Deckers-Passau L; de Halleux F
    Cancer Res; 1973 Oct; 33(10):2338-42. PubMed ID: 4582447
    [No Abstract]   [Full Text] [Related]  

  • 33. [Main problems of the method of clinical study of new antineoplastic agents].
    Astrakhan VI
    Vestn Akad Med Nauk SSSR; 1966; 21(4):85-92. PubMed ID: 4882836
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM
    Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in chemotherapy of solid tumors and malignant lymphomas (continued)].
    Alberto P
    Praxis; 1967 Dec; 56(49):1650-1 concl. PubMed ID: 4880021
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of adjuvant chemotherapeutic activity against primary and metastatic spontaneous murine tumors.
    Fugmann RA; Anderson JC; Stolfi RL; Martin DS
    Cancer Res; 1977 Feb; 37(2):496-500. PubMed ID: 832274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma.
    Hill SR; Pollard LA; Bibby MC
    Anticancer Res; 1992; 12(6B):2169-75. PubMed ID: 1295464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radiohepatography in evaluation of the effectiveness of treatment of reticuloblastomatosis].
    Kalika VL; Tabakman IuIu; Raevskii IG
    Med Radiol (Mosk); 1972 Sep; 17(9):20-4. PubMed ID: 4577234
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
    Gary-Bobo J
    J Radiol Electrol Med Nucl; 1971 Dec; 52(12):858-62. PubMed ID: 4113798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.